Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Atopic dermatitis has the highest burden of all skin diseases globally. While numerous systematic reviews and meta-analyses have attempted to estimate the burden of atopic dermatitis at country, regional, and global levels, the variability in research methodology often leads to the exclusion of significant portions of data or the aggregation of data representing disparate factors. As a result, improving the understanding of the burden of atopic dermatitis requires a thorough review of the methodologies currently in use.

Objective: This scoping review aims to identify and map the research methodology used in population-based epidemiological studies of atopic dermatitis in terms of the case definitions used, the severity assessment method, measures of frequency and key socio-demographic factors.

Methods: A systematic literature search was conducted covering an 18-month period from 1st January 2023 to 31st July 2024. Original, population-based studies were included if they reported the prevalence and/or incidence of atopic dermatitis. Abstract screening and data extraction was done in duplicate and blinded. Descriptive analyses stratified by geographic region and age group are presented in tabular and graphical form.

Results: A total of 111 studies were included across 48 countries. Data on atopic dermatitis prevalence used various diagnostic criteria, with studies defining cases by a physician diagnosis (69%), validated questionnaires (13%), and other methods (19%) with considerable heterogeneity between geographic regions. Nineteen studies (17%) reported the severity distribution. Geographical regions with the fewest studies on atopic dermatitis were the South-East Asian (4%) and African (3%) regions.

Conclusion: Recent population-based epidemiological studies on atopic dermatitis are highly heterogeneous, limiting meaningful comparisons across studies. Future research should aim to address this variability and fill key geographical gaps in the global burden data.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bjd/ljaf238DOI Listing

Publication Analysis

Top Keywords

atopic dermatitis
36
studies atopic
12
atopic
9
scoping review
8
dermatitis
8
burden atopic
8
population-based epidemiological
8
studies
8
epidemiological studies
8
studies included
8

Similar Publications

Allergic diseases, characterized by complex pathological mechanisms involving immune dysregulation and chronic inflammation, impose a substantial burden on global health. The Hippo signaling pathway, a highly conserved regulator of cell proliferation, apoptosis, immune homeostasis, and tissue repair, has recently emerged as a pivotal player in allergic disease pathogenesis. This review synthesizes current knowledge on the core components and physiological functions of the Hippo pathway, elucidates its mechanistic roles in major allergic disorders-including allergic asthma, allergic rhinitis, atopic dermatitis, and food allergies-and evaluates the therapeutic potential of targeting this pathway.

View Article and Find Full Text PDF

The interaction between the skin microbiome and antimicrobial peptides within the epidermal immune microenvironment: Bridging insights into atopic dermatitis.

Allergol Int

September 2025

Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan; Faculty of International Liberal Arts, Juntendo University, Tokyo, Japan. Electronic address:

The epidermal immune microenvironment is a multifaceted system in which the interplay between the skin microbiome and antimicrobial peptides plays a pivotal role in sustaining skin homeostasis and preventing dysbiosis. Disruption of these interactions can lead to inflammatory skin conditions such as atopic dermatitis. This review aims to explore the complex mechanisms by which antimicrobial peptides and the skin microbiome communicate within the epidermal immune microenvironment, emphasizing causal dynamics and the dual role of antimicrobial peptides.

View Article and Find Full Text PDF

Relationship between CFTR variants, sweat chloride responses, and lung function improvements.

Lancet Respir Med

September 2025

Department for Paediatric Pneumology, Allergology, and Neonatology and German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease, Hannover Medical School, 30625 Hannover, Germany. Electronic address:

View Article and Find Full Text PDF

Targeting PAR-2 in atopic dermatitis: Preclinical evaluation of the novel inhibitor E6795.

Biochem Biophys Res Commun

September 2025

Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; A∗STAR Skin Research Labs (A∗SRL), Skin Research Institute of Singapore (SRIS), Singapore Immunology Network (SIgN), Agency for Science, Technology, and Research (A∗STAR), 8A Biomedical Grove, IMMUNOS Buildi

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by eczematous lesions, intense itching, and compromised skin barrier function. Despite the advent of new therapeutics, many individuals still face insufficient disease control, high costs, and relapse. Protease-activated receptor 2 (PAR-2), overexpressed in AD lesions, plays a central role in promoting inflammation, itch, and alterations in epidermal homeostasis.

View Article and Find Full Text PDF